CUSIP: 817763105
Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
18,222,171
-
Share change
-
+4,215,421
-
Total reported value
-
$25,513,754
-
Put/Call ratio
-
35%
-
Price per share
-
$1.40
-
Number of holders
-
42
-
Value change
-
+$5,966,224
-
Number of buys
-
24
-
Number of sells
-
11
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2020
-
Previous quarter:
Q2 2020
Recent filing periods for CUSIP 817763105:
Institutional Holders of SESEN BIO INC - COM (SESN) as of Q3 2020
As of 30 Sep 2020,
SESEN BIO INC - COM (SESN) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,222,171 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., KINGDON CAPITAL MANAGEMENT, L.L.C., Eversept Partners, LP, MORGAN STANLEY, BRIDGEWAY CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, Qube Research & Technologies Ltd, and TWO SIGMA INVESTMENTS, LP.
This page lists
42
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.